Cargando…

Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation

Olfactory and rapid eye movement (REM) sleep deficits are commonly found in untreated subjects with a recent diagnosis of Parkinson’s disease (PD). Additionally, different studies report declines in olfactory performance during a short period of sleep deprivation. Mechanisms underlying these clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Lais S., Targa, Adriano D. S., Noseda, Ana Carolina D., Aurich, Mariana F., Da Cunha, Cláudio, Lima, Marcelo M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249459/
https://www.ncbi.nlm.nih.gov/pubmed/25520618
http://dx.doi.org/10.3389/fncel.2014.00383
_version_ 1782346858702569472
author Rodrigues, Lais S.
Targa, Adriano D. S.
Noseda, Ana Carolina D.
Aurich, Mariana F.
Da Cunha, Cláudio
Lima, Marcelo M. S.
author_facet Rodrigues, Lais S.
Targa, Adriano D. S.
Noseda, Ana Carolina D.
Aurich, Mariana F.
Da Cunha, Cláudio
Lima, Marcelo M. S.
author_sort Rodrigues, Lais S.
collection PubMed
description Olfactory and rapid eye movement (REM) sleep deficits are commonly found in untreated subjects with a recent diagnosis of Parkinson’s disease (PD). Additionally, different studies report declines in olfactory performance during a short period of sleep deprivation. Mechanisms underlying these clinical manifestations are poorly understood, and impairment of dopamine (DA) neurotransmission in the olfactory bulb and the nigrostriatal pathway may have important roles in olfaction and REM sleep disturbances. Therefore, we hypothesized that modulation of the dopaminergic D2 receptors in the olfactory bulb could provide a more comprehensive understanding of the olfactory deficits in PD and REM sleep deprivation (REMSD). We decided to investigate the olfactory, neurochemical, and histological alterations generated through the administration of piribedil (a selective D2 agonist) or raclopride (a selective D2 antagonist) within the glomerular layer of the olfactory bulb, in rats subjected to intranigral rotenone and REMSD. Our findings provide evidence of the occurrence of a negative correlation (r = −0.52, P = 0.04) between the number of periglomerular TH-ir neurons and the bulbar levels of DA in the rotenone, but not sham, groups. A significant positive correlation (r = 0.34, P = 0.03) was observed between nigrostriatal DA levels and olfactory discrimination index (DI) for the sham groups, indicating that increased DA levels in the substantia nigra pars compacta (SNpc) are associated with enhanced olfactory discrimination performance. Also, increased levels in bulbar and striatal DA were induced by piribedil in the rotenone control and rotenone REMSD groups, consistent with reductions in the DI. The present evidence reinforce the idea that DA produced by periglomerular neurons, particularly the bulbar dopaminergic D2 receptors, is an essential participant in olfactory discrimination processes, as the SNpc, and the striatum.
format Online
Article
Text
id pubmed-4249459
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-42494592014-12-17 Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation Rodrigues, Lais S. Targa, Adriano D. S. Noseda, Ana Carolina D. Aurich, Mariana F. Da Cunha, Cláudio Lima, Marcelo M. S. Front Cell Neurosci Neuroscience Olfactory and rapid eye movement (REM) sleep deficits are commonly found in untreated subjects with a recent diagnosis of Parkinson’s disease (PD). Additionally, different studies report declines in olfactory performance during a short period of sleep deprivation. Mechanisms underlying these clinical manifestations are poorly understood, and impairment of dopamine (DA) neurotransmission in the olfactory bulb and the nigrostriatal pathway may have important roles in olfaction and REM sleep disturbances. Therefore, we hypothesized that modulation of the dopaminergic D2 receptors in the olfactory bulb could provide a more comprehensive understanding of the olfactory deficits in PD and REM sleep deprivation (REMSD). We decided to investigate the olfactory, neurochemical, and histological alterations generated through the administration of piribedil (a selective D2 agonist) or raclopride (a selective D2 antagonist) within the glomerular layer of the olfactory bulb, in rats subjected to intranigral rotenone and REMSD. Our findings provide evidence of the occurrence of a negative correlation (r = −0.52, P = 0.04) between the number of periglomerular TH-ir neurons and the bulbar levels of DA in the rotenone, but not sham, groups. A significant positive correlation (r = 0.34, P = 0.03) was observed between nigrostriatal DA levels and olfactory discrimination index (DI) for the sham groups, indicating that increased DA levels in the substantia nigra pars compacta (SNpc) are associated with enhanced olfactory discrimination performance. Also, increased levels in bulbar and striatal DA were induced by piribedil in the rotenone control and rotenone REMSD groups, consistent with reductions in the DI. The present evidence reinforce the idea that DA produced by periglomerular neurons, particularly the bulbar dopaminergic D2 receptors, is an essential participant in olfactory discrimination processes, as the SNpc, and the striatum. Frontiers Media S.A. 2014-12-01 /pmc/articles/PMC4249459/ /pubmed/25520618 http://dx.doi.org/10.3389/fncel.2014.00383 Text en Copyright © 2014 Rodrigues, Targa, Noseda, Aurich, Da Cunha and Lima. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Rodrigues, Lais S.
Targa, Adriano D. S.
Noseda, Ana Carolina D.
Aurich, Mariana F.
Da Cunha, Cláudio
Lima, Marcelo M. S.
Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
title Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
title_full Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
title_fullStr Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
title_full_unstemmed Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
title_short Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
title_sort olfactory impairment in the rotenone model of parkinson’s disease is associated with bulbar dopaminergic d2 activity after rem sleep deprivation
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249459/
https://www.ncbi.nlm.nih.gov/pubmed/25520618
http://dx.doi.org/10.3389/fncel.2014.00383
work_keys_str_mv AT rodrigueslaiss olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation
AT targaadrianods olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation
AT nosedaanacarolinad olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation
AT aurichmarianaf olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation
AT dacunhaclaudio olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation
AT limamarceloms olfactoryimpairmentintherotenonemodelofparkinsonsdiseaseisassociatedwithbulbardopaminergicd2activityafterremsleepdeprivation